Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Rafael Rubio(Research Institute Hospital 12 de Octubre), A. Sureda, Mireia Morgades(Josep Carreras Leukaemia Research Institute), Juan Berenguer(Instituto de Salud Carlos III), Eulalia Valencia, Herminia Esteban(Fundación Seimc-Gesida), Beatriz Mahíllo(Organización Nacional de Trasplantes), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Eugènia Abella(Hospital Del Mar), Josep‐María Ribera(Universitat Autònoma de Barcelona), Armando López‐Guillermo(Barcelona Supercomputing Center), Pilar Miralles(Hospital General Universitario Gregorio Marañón)
Cited by 123
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k